Correction of Breast Asymmetry in Lexington Kentucky
A slight breast asymmetry is very common, when the asymmetry is very remarkable you might want to correct the asymmetry. The correction can be done either by augmentation of the smaller breast or reduction of the large one. The decision between the options is made together with the surgeon, depending on your anatomy and the degree of asymmetry.
You should be above age 18, not nursing or pregnant and in good general health to undergo the correction.
If you're going through the augmentation procedure, the surgeon will make the incision in your armpit, around the nipple or under the breast fold. Then he'll separate the skin from the breast tissue in order to insert the implants. The insertion can be above or below the chest muscles. Most of the implants today are filled with silicon and come in different sizes and shapes.
The reduction procedure involves a vertical incision from the nipple down and a horizontal incision below the breast fold. The extra fat is removed using a liposuction and the breast size is adjusted to the other one.
The length of each procedure depends on the degree of asymmetry and procedure technique. After the surgery you'll have bandages around your chest, sometimes a drainage tube is also placed to avoid blood and fluid collection. Breast augmentation stretches the tissue, therefore there may be a significant amount of pain after the surgery, especially during the first 48 hours. Painkiller antibiotics and anti inflammatory drugs are often prescribed.
Breast reduction involves a larger scar but it goes through less sensitive areas, therefore the pain is less and can be easily treated with painkillers.
Every procedure has its risks. Augmentation may result is implant contraction, rupture of the filling, the implant may move and nipple sensation may be lost. Reduction is usually safe, but can cause bleeding, infection and delayed healing.
Expect to feel tired and sore during the first 48-72 hours. You'll be able to go to work after a week or so, but you should avoid strenuous activities for up to 6 weeks. Complete recovery usually takes 2 month. Until then expect that your scars will be pink and sensitive for 6 weeks, then they'll begin to fade. It is normal for your breasts to be swollen for 3-4 weeks.
More Lexington info...
Lexington Do Despite the relative small size of this South-North straddling city, Lexington offers a surprisingly delightful palette of interesting activities. Whether you choose to explore some of the world-class and stunning horse farms ringing the city, hit up some of the surprisingly upscale shopping venues, take in a play at the Downtown Arts Center or the Lexington Opera House, tour the oldest university west of the Allegheny Mountains (Transylvania University), catch an insanely popular UK basketball game (Rupp Arena) or sample one of the myriad great restaurants that have sprung up all over town, you can be sure your experience here will not be a bland one.
Lexington By car Travellers usually access Lexington via one of the two major interstates that arc around the northern and western borders of the city. I-64 runs from east to west, most notably connecting Lexington with the largest city in Kentucky, Louisville, to the west. I-75 runs north-south, connecting Lexington with Cincinnati and Knoxville respectively. Neither interstate actually penetrates into the city, so motorists must take one of many possible exits that lead inbound. Several major streets radiate from downtown in a spiderweb pattern, and New Circle road runs in a complete circle around the city. Lexington is also served by the Martha Layne Collins Bluegrass Parkway, originating in Elizabethtown, KY.
Plastic Surgery News...
- Scientists have identified a genetic variant that not only makes
smokers more susceptible to nicotine addiction but also increases
their risk of developing two smoking-related diseases, lung cancer
and peripheral arterial disease. The research was supported by
the National Institute on Drug Abuse (NIDA), part of the National
Institutes of Health (NIH).
- A review on sitagliptin in the management of type 2 diabetes has been published in the American Journal of Health-System Pharmacy, covering the following:
• Pharmacology
• Pharmacokinetics and pharmacodynamics
• Clinical efficacy
• Safety
• Dosage and administration
• Special populations
• Pharmacoeconomics
• Place in therapy
The authors summarise: “Sitagliptin is a DPP4 inhibitor shown to increase insulin release and decrease glucagon levels by preventing the inactivation of the incretin hormones GLP-1 and GIP. The clinical trials reviewed have demonstrated that sitagliptin, either alone or in combination with metformin or thiazolidinediones, is effective in reducing HbA1c values, FPG levels, and two-hour PPG levels in patients with type 2 diabetes. Sitagliptin should be considered as monotherapy or in combination with metformin or thiazolidinediones for patients with type 2 diabetes who have been unable to attain the target HbA1c value. Sitagliptin is generally well tolerated in clinical trials, with the rate of adverse events being similar to placebo and a low frequency of hypoglycemia. The addition of sitagliptin to a patient’s oral antidiabetic regimen would necessitate close monitoring for adverse events and possible drug interactions. At the present time, no ongoing trials are evaluating the effects of sitagliptin on preventing microvascular and macrovascular conditions. Further clinical and pharmacoeconomic studies are needed to assess sitagliptin’s cost-effectiveness, long-term tolerability, and efficacy”.